CUSIP 64125C109COMNBIXQ4 2025
32 filings · latest Jan 21, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 12.83M | $1.82B |
| 2 | Vanguard Group Inc | 9.70M | $1.38B |
| 3 | Dodge & Cox | 5.51M | $781.21M |
| 4 | Jpmorgan Chase & Co | 5.20M | $737.57M |
| 5 | State Street Corp | 4.24M | $601.74M |
| 6 | Aqr Capital Management LLC | 3.27M | $462.65M |
| 7 | Renaissance Technologies LLC | 2.24M | $317.53M |
| 8 | Geode Capital Management, LLC | 2.06M | $291.34M |
| 9 | Wellington Management Group LLP |
| 4 | Mar 6, 2025 | The Vanguard Group | 13G/A | 10.2% | 10.13M | SEC |
| 5 | Feb 5, 2025 | State Street Corporation | 13G | 4.8% | 4.89M | SEC |
| 6 | Oct 17, 2024 | State Street Corp | 13G | 5.1% | 5.15M | SEC |
| 7 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.9% | 9.71M | SEC |
| 8 | Jan 23, 2024 | Blackrock Inc. | 13G/A | 13.9% | 13.65M | SEC |
| 9 | Feb 9, 2023 | Janus Henderson Group PLC | 13G/A | 2.5% | 2.42M | SEC |
| 10 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 9.7% | 9.34M | SEC |
See the full Schedule 13D/13G history for Neurocrine Biosciences Inc.
Unlock full history| 1.74M |
| $247.43M |
| 10 | Bellevue Group AG | 1.70M | $241.58M |